Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Core Insights - Arcutis Biotherapeutics, Inc. is participating in the Goldman Sachs 46th Annual Global Healthcare Conference from June 9-11, 2025, with a fireside chat scheduled for June 10, 2025, at 4:00 pm EDT [1] - The company focuses on developing innovations in immuno-dermatology, addressing the needs of patients with immune-mediated dermatological diseases [2] Company Overview - Arcutis is a commercial-stage medical dermatology company with a commitment to addressing urgent patient needs in dermatology [2] - The company has a growing portfolio of advanced targeted topicals approved for treating three major inflammatory skin diseases [2] - Arcutis utilizes a unique dermatology development platform and expertise to create differentiated therapies against biologically validated targets, resulting in a robust pipeline for various inflammatory dermatological conditions, including atopic dermatitis and alopecia areata [2]